Gollob Jared
SEC insider (Form 3/4/5 filer). CIK 0001821198. Chief Medical Officer at Kymera Therapeutics, Inc. (KYMR). 27 reported Form 4/5 transactions since Sep 2024; latest on Mar 4, 2026. Located in WATERTOWN, MA.
Companies Gollob Jared has filed insider reports for
- Kymera Therapeutics, Inc. (KYMR): Officer, Chief Medical Officer
Gollob Jared
CIK: 0001821198
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Kymera Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (27 total)
- Mar 4, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect1.4K shares at avg. $85.78$123K - Mar 4, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect2.5K shares at avg. $85.04$214K - Mar 4, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect492 shares at avg. $84.00$41K - Mar 4, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect447 shares at avg. $86.62$39K - Mar 2, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect1.1K shares at avg. $88.50$93K - Mar 2, 2026KYMR
Kymera Therapeutics, Inc.
AwardDirect17.7K shares- - Mar 2, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect3K shares at avg. $89.66$273K - Mar 2, 2026KYMR
Kymera Therapeutics, Inc.
SaleDirect1.5K shares at avg. $87.75$133K - Dec 8, 2025KYMR
Kymera Therapeutics, Inc.
SaleDirect13.8K shares at avg. $87.37$1.2M - Dec 8, 2025KYMR
Kymera Therapeutics, Inc.
ExerciseDirect49.3K shares at avg. $5.33$263K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 4, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 1,437 | $85.78 | $123,267 | Direct |
| Mar 4, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 2,519 | $85.04 | $214,207 | Direct |
| Mar 4, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 492 | $84.00 | $41,326 | Direct |
| Mar 4, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 447 | $86.62 | $38,721 | Direct |
| Mar 2, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 1,055 | $88.50 | $93,368 | Direct |
| Mar 2, 2026 | KYMR Kymera Therapeutics, Inc. | Award | 17,650 | - | $0 | Direct |
| Mar 2, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 3,048 | $89.66 | $273,276 | Direct |
| Mar 2, 2026 | KYMR Kymera Therapeutics, Inc. | Sale | 1,510 | $87.75 | $132,504 | Direct |
| Dec 8, 2025 | KYMR Kymera Therapeutics, Inc. | Sale | 13,759 | $87.37 | $1,202,139 | Direct |
| Dec 8, 2025 | KYMR Kymera Therapeutics, Inc. | Exercise | 49,307 | $5.33 | $262,806 | Direct |
1-10 of 27 transactions